Takeda, Dey settle for $6.75M for inflating drug prices
|Two pharma companies forced to pay CMS over drug inflation charges. |
Source: Piper Report
Alabama Attorney General Troy King said that Takeda inflated the price of the diabetes drug Actos. The claim against Dey involved a number of drugs prescribed primarily for pulmonary diseases and asthma.
Despite the settlement, the Osaka, Japan-based Takeda and Dey, a unit of the Pittsburgh-based Mylan, said they do not admit unlawful conduct.
King filed a lawsuit in 2005 alleging massive overcharges to the Alabama Medicaid Agency over many years. He said his case will continue against 71 other defendants.